Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The company aims to overcome the limitations of existing therapies for clinically proven kinase targets. They develop innovative small molecules to address various cancer challenges. Nuvalent is advancing a robust pipeline with investigational candidates for different types of cancer.
Fundz sees it the moment Nuvalent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical